Literature DB >> 21182401

Expression of circadian clock and melatonin receptors within cultured rat cardiomyocytes.

Rodrigo A Peliciari-Garcia1, Melissa M Zanquetta, Jéssica Andrade-Silva, Dayane A Gomes, Maria Luiza Barreto-Chaves, José Cipolla-Neto.   

Abstract

Melatonin, the pineal gland hormone, provides entrainment of many circadian rhythms to the ambient light/dark cycle. Recently, cardiovascular studies have demonstrated melatonin interactions with many physiological processes and diseases, such as hypertension and cardiopathologies. Although membrane melatonin receptors (MT1, MT2) and the transcriptional factor RORα have been reported to be expressed in the heart, there is no evidence of the cell-type expressing receptors as well as the possible role of melatonin on the expression of the circadian clock of cardiomyocytes, which play an important role in cardiac metabolism and function. Therefore, the aim of this study was to evaluate the mRNA and protein expressions of MT1, MT2, and RORα and to determine whether melatonin directly influences expression of circadian clocks within cultured rat cardiomyocytes. Adult rat cardiomyocyte cultures were created, and the cells were stimulated with 1 nM melatonin or vehicle. Gene expressions were assayed by real-time polymerase chain reaction (PCR). The mRNA and protein expressions of membrane melatonin receptors and RORα were established within adult rat cardiomyocytes. Two hours of melatonin stimulation did not alter the expression pattern of the analyzed genes. However, given at the proper time, melatonin kept Rev-erbα expression chronically high, specifically 12 h after melatonin treatment, avoiding the rhythmic decline of Rev-erbα mRNA. The blockage of MT1 and MT2 by luzindole did not alter the observed melatonin-induced expression of Rev-erbα mRNA, suggesting the nonparticipation of MT1 and MT2 on the melatonin effect within cardiomyocytes. It is possible to speculate that melatonin, in adult rat cardiomyocytes, may play an important role in the light signal transduction to peripheral organs, such as the heart, modulating its intrinsic rhythmicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21182401     DOI: 10.3109/07420528.2010.525675

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  10 in total

Review 1.  An overview of the emerging interface between cardiac metabolism, redox biology and the circadian clock.

Authors:  Rodrigo A Peliciari-Garcia; Victor Darley-Usmar; Martin E Young
Journal:  Free Radic Biol Med       Date:  2018-02-10       Impact factor: 7.376

2.  Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Natticha Sumneang; Chayodom Maneechote; Busarin Arunsak; Titikorn Chunchai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2022-05-19       Impact factor: 9.261

3.  Interrelationship between 3,5,3´-triiodothyronine and the circadian clock in the rodent heart.

Authors:  Rodrigo Antonio Peliciari-Garcia; Rafael Maso Prévide; Maria Tereza Nunes; Martin Elliot Young
Journal:  Chronobiol Int       Date:  2016-09-23       Impact factor: 2.877

4.  Repercussions of hypo and hyperthyroidism on the heart circadian clock.

Authors:  Rodrigo A Peliciari-Garcia; Paula Bargi-Souza; Martin E Young; Maria Tereza Nunes
Journal:  Chronobiol Int       Date:  2017-11-07       Impact factor: 2.877

5.  Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia.

Authors:  Tobias Eckle; Katherine Hartmann; Stephanie Bonney; Susan Reithel; Michel Mittelbronn; Lori A Walker; Brian D Lowes; Jun Han; Christoph H Borchers; Peter M Buttrick; Douglas J Kominsky; Sean P Colgan; Holger K Eltzschig
Journal:  Nat Med       Date:  2012-04-15       Impact factor: 53.440

Review 6.  Maternal Melatonin Deficiency Leads to Endocrine Pathologies in Children in Early Ontogenesis.

Authors:  Dmitry O Ivanov; Inna I Evsyukova; Ekaterina S Mironova; Victoria O Polyakova; Igor M Kvetnoy; Ruslan A Nasyrov
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

Review 7.  New insights into the role of melatonin in diabetic cardiomyopathy.

Authors:  Keming Huang; Xianling Luo; Yi Zhong; Li Deng; Jian Feng
Journal:  Pharmacol Res Perspect       Date:  2022-02

Review 8.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20

9.  Melatonin modulates baroreflex control via area postrema.

Authors:  Luciana A Campos; Jose Cipolla-Neto; Lisete C Michelini
Journal:  Brain Behav       Date:  2013-02-17       Impact factor: 2.708

10.  Developmental and light-entrained expression of melatonin and its relationship to the circadian clock in the sea anemone Nematostella vectensis.

Authors:  Rafael Peres; Adam M Reitzel; Yale Passamaneck; Solange Castro Afeche; José Cipolla-Neto; Antonio Carlos Marques; Mark Q Martindale
Journal:  Evodevo       Date:  2014-08-14       Impact factor: 2.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.